The United States, Eli Lilly, and Novo Nordisk AS announced an agreement to lower the price of GLP-1 weight loss drugs, with both companies pricing it at $245 per month

Wallstreetcn
2025.11.06 17:05
portai
I'm PortAI, I can summarize articles.

The United States, Eli Lilly, and Novo Nordisk AS announced an agreement to lower the price of GLP-1 weight loss drugs, with the two companies pricing it at $245 per month. Risk warning and disclaimer: The market has risks, and investment requires caution. This article does not constitute personal investment advice and does not take into account the specific investment goals, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article align with their specific circumstances. Investing based on this is at one's own risk

The United States, Eli Lilly, and Novo Nordisk AS announced an agreement to lower the price of GLP-1 weight loss drugs, with both companies pricing it at $245 per month.

Risk Warning and Disclaimer

The market has risks, and investment should be cautious. This article does not constitute personal investment advice and does not take into account the specific investment goals, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment based on this is at one's own risk

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.